{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T01:03:22Z","timestamp":1728176602430},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00105-020-04548-9","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:06:47Z","timestamp":1581937607000},"page":"284-292","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anale Dysplasien und Analkarzinom"],"prefix":"10.1007","volume":"71","author":[{"given":"Ulrike","family":"Wieland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Oellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"4548_CR1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani\u00a0JA, Winter\u00a0KA, Gunderson\u00a0LL et\u00a0al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a\u00a0randomized controlled trial. JAMA 299:1914\u20131921","journal-title":"JAMA"},{"key":"4548_CR2","volume-title":"AJCC cancer staging manual","year":"2017","unstructured":"Amin\u00a0MBG, Meyer\u00a0LR, Edge\u00a0S, Greene\u00a0F, Byrd\u00a0DR, Brookland\u00a0RK, Washington\u00a0MK, Compton\u00a0CC et\u00a0al (Hrsg) (2017) AJCC cancer staging manual. Springer, New York"},{"key":"4548_CR3","first-page":"CD009069","volume":"5","author":"M Arbyn","year":"2018","unstructured":"Arbyn\u00a0M, Xu\u00a0L, Simoens\u00a0C et\u00a0al (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 5:CD9069","journal-title":"Cochrane Database Syst Rev"},{"key":"4548_CR4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/DCR.0000000000001384","volume":"62","author":"Y Arens","year":"2019","unstructured":"Arens\u00a0Y, Gaisa\u00a0M, Goldstone\u00a0SE et al (2019) Risk of invasive anal cancer in HIV-infected patients with high-grade anal dysplasia: a population-based cohort study. Dis Colon Rectum 62:934\u2013940","journal-title":"Dis Colon Rectum"},{"key":"4548_CR5","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S1470-2045(15)00292-2","volume":"16","author":"MP Bernardi","year":"2015","unstructured":"Bernardi\u00a0MP, Ngan\u00a0SY, Michael\u00a0M et\u00a0al (2015) Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention. Lancet Oncol 16:e611\u2013621","journal-title":"Lancet Oncol"},{"key":"4548_CR6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ijc.28431","volume":"134","author":"JM Berry","year":"2014","unstructured":"Berry\u00a0JM, Jay\u00a0N, Cranston\u00a0RD et al (2014) Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer 134:1147\u20131155","journal-title":"Int J Cancer"},{"key":"4548_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.soc.2003.12.003","volume":"13","author":"JM Berry","year":"2004","unstructured":"Berry\u00a0JM, Palefsky\u00a0JM, Welton\u00a0ML (2004) Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 13:355\u2013373","journal-title":"Surg Oncol Clin N Am"},{"key":"4548_CR8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jis458","volume":"206","author":"FA Castro","year":"2012","unstructured":"Castro\u00a0FA, Quint\u00a0W, Gonzalez\u00a0P et\u00a0al (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J\u00a0Infect Dis 206:1103\u20131110","journal-title":"J Infect Dis"},{"key":"4548_CR9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","volume":"99","author":"AK Chaturvedi","year":"2007","unstructured":"Chaturvedi\u00a0AK, Engels\u00a0EA, Gilbert\u00a0ES et al (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J\u00a0Natl Cancer Inst 99:1634\u20131643","journal-title":"J Natl Cancer Inst"},{"key":"4548_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/505219","volume":"43","author":"EY Chiao","year":"2006","unstructured":"Chiao\u00a0EY, Giordano\u00a0TP, Palefsky\u00a0JM et al (2006) Screening HIV-infected individuals for anal cancer precursor lesions: a\u00a0systematic review. Clin Infect Dis 43:223\u2013233","journal-title":"Clin Infect Dis"},{"key":"4548_CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(04)01410-X","volume":"5","author":"MA Clark","year":"2004","unstructured":"Clark\u00a0MA, Hartley\u00a0A, Geh\u00a0JI (2004) Cancer of the anal canal. Lancet Oncol 5:149\u2013157","journal-title":"Lancet Oncol"},{"key":"4548_CR12","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1111\/jsm.12670","volume":"11","author":"ER Coskuner","year":"2014","unstructured":"Coskuner\u00a0ER, Ozkan\u00a0TA, Karakose\u00a0A et\u00a0al (2014) Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV infection: a\u00a0randomized study. J\u00a0Sex Med 11:2785\u20132791","journal-title":"J Sex Med"},{"key":"4548_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz219","author":"AA Deshmukh","year":"2019","unstructured":"Deshmukh\u00a0AA, Suk\u00a0R, Shiels\u00a0MS et\u00a0al (2019) Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001\u20132015. J\u00a0Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djz219","journal-title":"J Natl Cancer Inst"},{"key":"4548_CR14","volume-title":"European AIDS clinical society (EACS) guidelines","author":"EACS","year":"2019","unstructured":"EACS (2019) European AIDS clinical society (EACS) guidelines (Version 10.0)"},{"key":"4548_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1158\/1055-9965.EPI-19-0601","volume":"29","author":"MT Faber","year":"2020","unstructured":"Faber\u00a0MT, Frederiksen\u00a0K, Palefsky\u00a0JM et\u00a0al (2020) Risk of anal cancer following benign anal disease and anal cancer precursor lesions: a Danish nationwide cohort study. Cancer Epidemiol Biomarkers Prev 29:185\u2013192","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4548_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","volume":"98","author":"I Fraunholz","year":"2011","unstructured":"Fraunholz\u00a0I, Rabeneck\u00a0D, Gerstein\u00a0J et al (2011) Concurrent chemoradiotherapy with 5\u2011fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy? Radiother Oncol 98:99\u2013104","journal-title":"Radiother Oncol"},{"key":"4548_CR17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jdv.13539","volume":"30","author":"W Fuchs","year":"2016","unstructured":"Fuchs\u00a0W, Wieland\u00a0U, Skaletz-Rorowski\u00a0A et al (2016) The male screenING study: prevalence of HPV-related genital and anal lesions in an urban cohort of HIV-positive men in Germany. J\u00a0Eur Acad Dermatol Venereol 30:995\u20131001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4548_CR18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/JCO.2016.69.1667","volume":"35","author":"MK Garg","year":"2017","unstructured":"Garg\u00a0MK, Zhao\u00a0F, Sparano\u00a0JA et al (2017) Cetuximab plus chemoradiotherapy in Immunocompetent patients with anal carcinoma: a phase II eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205). J\u00a0Clin Oncol 35:718\u2013726","journal-title":"J Clin Oncol"},{"key":"4548_CR19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","volume":"40","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones\u00a0R, Nilsson\u00a0PJ, Aschele\u00a0C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 40:1165\u20131176","journal-title":"Eur J Surg Oncol"},{"key":"4548_CR20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/651620","volume":"201","author":"MT Goodman","year":"2010","unstructured":"Goodman\u00a0MT, Shvetsov\u00a0YB, Mcduffie\u00a0K et\u00a0al (2010) Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the hawaii HPV cohort study. J\u00a0Infect Dis 201:1331\u20131339","journal-title":"J Infect Dis"},{"key":"4548_CR21","first-page":"586","volume":"115","author":"T Gredner","year":"2018","unstructured":"Gredner\u00a0T, Behrens\u00a0G, Stock\u00a0C et\u00a0al (2018) Cancers due to infection and selected environmental factors. Dtsch Arztebl Int 115:586\u2013593","journal-title":"Dtsch Arztebl Int"},{"key":"4548_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich\u00a0AE, van Leeuwen\u00a0MT, Falster\u00a0MO et al (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a\u00a0meta-analysis. Lancet 370:59\u201367","journal-title":"Lancet"},{"key":"4548_CR23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","volume":"16","author":"T Harder","year":"2018","unstructured":"Harder\u00a0T, Wichmann\u00a0O, Klug\u00a0SJ et\u00a0al (2018) Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a\u00a0systematic review. BMC Med 16:110","journal-title":"BMC Med"},{"key":"4548_CR24","doi-asserted-by":"crossref","first-page":"212.e1","DOI":"10.1016\/j.ajog.2016.02.021","volume":"215","author":"A Hildesheim","year":"2016","unstructured":"Hildesheim\u00a0A, Gonzalez\u00a0P, Kreimer\u00a0AR et\u00a0al (2016) Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol 215:212.e1\u2013212.e15","journal-title":"Am J Obstet Gynecol"},{"key":"4548_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/LGT.0000000000000458","volume":"23","author":"RJ Hillman","year":"2019","unstructured":"Hillman\u00a0RJ, Berry-Lawhorn\u00a0JM, Ong\u00a0JJ et al (2019) International anal neoplasia society guidelines for the practice of digital anal rectal examination. J\u00a0Low Genit Tract Dis 23:138\u2013146","journal-title":"J Low Genit Tract Dis"},{"key":"4548_CR26","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00330-017-5284-z","volume":"28","author":"A Hocquelet","year":"2018","unstructured":"Hocquelet\u00a0A, Auriac\u00a0T, Perier\u00a0C et al (2018) Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy. Eur Radiol 28:2801\u20132811","journal-title":"Eur Radiol"},{"key":"4548_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz614","author":"VW Jongen","year":"2019","unstructured":"Jongen\u00a0VW, Richel\u00a0O, Marra\u00a0E et al (2019) Anal squamous intraepithelial lesions (aSIL) in HIV-positive MSM: incidence and risk factors of aSIL, and of progression and clearance of low-grade aSIL. J\u00a0Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz614","journal-title":"J Infect Dis"},{"key":"4548_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/OLQ.0b013e3181f70253","volume":"38","author":"EM Kojic","year":"2011","unstructured":"Kojic\u00a0EM, Cu-Uvin\u00a0S, Conley\u00a0L et al (2011) Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV\/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis 38:253\u2013259","journal-title":"Sex Transm Dis"},{"key":"4548_CR29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jaad.2004.11.026","volume":"52","author":"A Kreuter","year":"2005","unstructured":"Kreuter\u00a0A, Brockmeyer\u00a0NH, Hochdorfer\u00a0B et\u00a0al (2005) Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J\u00a0Am Acad Dermatol 52:603\u2013608","journal-title":"J Am Acad Dermatol"},{"key":"4548_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00105-009-1810-5","volume":"61","author":"A Kreuter","year":"2010","unstructured":"Kreuter\u00a0A, Brockmeyer\u00a0NH, Wieland\u00a0U (2010) Anal intraepithelial neoplasia and anal carcinoma: an increasing problem in HIV patients. Hautarzt 61:21\u201326","journal-title":"Hautarzt"},{"key":"4548_CR31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2133.2010.09712.x","volume":"162","author":"A Kreuter","year":"2010","unstructured":"Kreuter\u00a0A, Potthoff\u00a0A, Brockmeyer\u00a0NH et al (2010) Anal carcinoma in human immunodeficiency virus-positive men: results of a\u00a0prospective study from Germany. Br J Dermatol 162:1269\u20131277","journal-title":"Br J Dermatol"},{"key":"4548_CR32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamadermatol.2016.2503","volume":"152","author":"A Kreuter","year":"2016","unstructured":"Kreuter\u00a0A, Siorokos\u00a0C, Oellig\u00a0F et al (2016) High-grade dysplasia in anogenital warts of HIV-positive men. JAMA Dermatol 152:1225\u20131230","journal-title":"JAMA Dermatol"},{"key":"4548_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","volume":"18","author":"C Lin","year":"2018","unstructured":"Lin\u00a0C, Franceschi\u00a0S, Clifford\u00a0GM (2018) Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a\u00a0systematic review and meta-analysis. Lancet Infect Dis 18:198\u2013206","journal-title":"Lancet Infect Dis"},{"key":"4548_CR34","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","volume":"19","author":"C Lin","year":"2019","unstructured":"Lin\u00a0C, Slama\u00a0J, Gonzalez\u00a0P et al (2019) Cervical determinants of anal HPV infection and high-grade anal lesions in women: a\u00a0collaborative pooled analysis. Lancet Infect Dis 19:880\u2013891","journal-title":"Lancet Infect Dis"},{"key":"4548_CR35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","volume":"13","author":"DA Machalek","year":"2012","unstructured":"Machalek\u00a0DA, Poynten\u00a0M, Jin\u00a0F et al (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a\u00a0systematic review and meta-analysis. Lancet Oncol 13:487\u2013500","journal-title":"Lancet Oncol"},{"key":"4548_CR36","doi-asserted-by":"crossref","first-page":"ofz291","DOI":"10.1093\/ofid\/ofz291","volume":"6","author":"RS Mboumba Bouassa","year":"2019","unstructured":"Mboumba Bouassa\u00a0RS, Belec\u00a0L, Gubavu\u00a0C et al (2019) High prevalence of anal and oral high-risk human papillomavirus in human Immunodeficiency virus-uninfected French men who have sex with men and use preexposure prophylaxis. Open Forum Infect Dis 6:ofz291","journal-title":"Open Forum Infect Dis"},{"key":"4548_CR37","doi-asserted-by":"crossref","first-page":"e1006211","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride\u00a0AA, Warburton\u00a0A (2017) The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog 13:e1006211","journal-title":"PLoS Pathog"},{"key":"4548_CR38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","volume":"18","author":"VK Morris","year":"2017","unstructured":"Morris\u00a0VK, Salem\u00a0ME, Nimeiri\u00a0H et al (2017) Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a\u00a0multicentre, single-arm, phase 2 study. Lancet Oncol 18:446\u2013453","journal-title":"Lancet Oncol"},{"key":"4548_CR39","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/LGT.0000000000000117","volume":"19","author":"AB Moscicki","year":"2015","unstructured":"Moscicki\u00a0AB, Darragh\u00a0TM, Berry-Lawhorn\u00a0JM et al (2015) Screening for anal cancer in women. J\u00a0Low Genit Tract Dis 19:S27\u201342","journal-title":"J Low Genit Tract Dis"},{"key":"4548_CR40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-06-0997","volume":"16","author":"CM Nielson","year":"2007","unstructured":"Nielson\u00a0CM, Flores\u00a0R, Harris\u00a0RB et\u00a0al (2007) Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 16:1107\u20131114","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4548_CR41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1086\/521632","volume":"196","author":"CM Nielson","year":"2007","unstructured":"Nielson\u00a0CM, Harris\u00a0RB, Dunne\u00a0EF et\u00a0al (2007) Risk factors for anogenital human papillomavirus infection in men. J\u00a0Infect Dis 196:1137\u20131145","journal-title":"J Infect Dis"},{"key":"4548_CR42","first-page":"17","volume":"3","author":"D Oberle","year":"2018","unstructured":"Oberle\u00a0D, Drechsel-B\u00e4uerle\u00a0U, Keller-Stanislawski\u00a0B (2018) Sicherheit der Impfung gegen humane Papillomviren (HPV). Bull Arzneimittelsicherh 3:17\u201323","journal-title":"Bull Arzneimittelsicherh"},{"key":"4548_CR43","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","volume":"26","author":"C Oehler-Janne","year":"2008","unstructured":"Oehler-Janne\u00a0C, Huguet\u00a0F, Provencher\u00a0S et al (2008) HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a\u00a0multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J\u00a0Clin Oncol 26:2550\u20132557","journal-title":"J Clin Oncol"},{"key":"4548_CR44","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdx029","volume":"28","author":"PA Ott","year":"2017","unstructured":"Ott\u00a0PA, Piha-Paul\u00a0SA, Munster\u00a0P et al (2017) Safety and antitumor activity of the anti-PD\u20111 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal. Ann Oncol 28:1036\u20131041","journal-title":"Ann Oncol"},{"key":"4548_CR45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky\u00a0JM, Giuliano\u00a0AR, Goldstone\u00a0S et\u00a0al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N\u00a0Engl J Med 365:1576\u20131585","journal-title":"N Engl J Med"},{"key":"4548_CR46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.aids.0000181012.62385.4a","volume":"19","author":"JM Palefsky","year":"2005","unstructured":"Palefsky\u00a0JM, Holly\u00a0EA, Efirdc\u00a0JT et al (2005) Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19:1407\u20131414","journal-title":"AIDS"},{"key":"4548_CR47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","volume":"177","author":"JM Palefsky","year":"1998","unstructured":"Palefsky\u00a0JM, Holly\u00a0EA, Ralston\u00a0ML et al (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J\u00a0Infect Dis 177:361\u2013367","journal-title":"J Infect Dis"},{"key":"4548_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz831","author":"B Revollo","year":"2019","unstructured":"Revollo\u00a0B, Videla\u00a0S, Llibre\u00a0JM et al (2019) Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciz831","journal-title":"Clin Infect Dis"},{"key":"4548_CR49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1470-2045(13)70067-6","volume":"14","author":"O Richel","year":"2013","unstructured":"Richel\u00a0O, de Vries\u00a0HJ, van Noesel\u00a0CJ et al (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol 14:346\u2013353","journal-title":"Lancet Oncol"},{"key":"4548_CR50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/QAI.0000000000000675","volume":"69","author":"O Richel","year":"2015","unstructured":"Richel\u00a0O, Van Der Zee\u00a0RP, Smit\u00a0C et al (2015) Anal cancer in the HIV-positive population: slowly declining incidence after a\u00a0decade of cART. J\u00a0Acquir Immune Defic Syndr 69:602\u2013605","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4548_CR51","first-page":"313","volume":"34","author":"Robert-Koch-Institut","year":"2019","unstructured":"Robert-Koch-Institut (2019) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 34:313\u2013364","journal-title":"Epidemiol Bull"},{"key":"4548_CR52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/AOG.0b013e31820bfb16","volume":"117","author":"AM Saleem","year":"2011","unstructured":"Saleem\u00a0AM, Paulus\u00a0JK, Shapter\u00a0AP et al (2011) Risk of anal cancer in a\u00a0cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol 117:643\u2013649","journal-title":"Obstet Gynecol"},{"key":"4548_CR53","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","volume":"36","author":"J Schiller","year":"2018","unstructured":"Schiller\u00a0J, Lowy\u00a0D (2018) Explanations for the high potency of HPV prophylactic vaccines. Vaccine 36:4768\u20134773","journal-title":"Vaccine"},{"key":"4548_CR54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","volume":"68","author":"V Senkomago","year":"2019","unstructured":"Senkomago\u00a0V, Henley\u00a0SJ, Thomas\u00a0CC et al (2019) Human papillomavirus-attributable cancers\u2014United States, 2012\u20132016. Mmwr Morb Mortal Wkly Rep 68:724\u2013728","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"key":"4548_CR55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjd.14567","volume":"175","author":"ML Siegenbeek van Heukelom","year":"2016","unstructured":"Siegenbeek van Heukelom\u00a0ML, Richel\u00a0O, de Vries\u00a0HJ et al (2016) Low- and high-risk human papillomavirus genotype infections in intra-anal warts in HIV-positive men who have sex with men. Br J Dermatol 175:735\u2013743","journal-title":"Br J Dermatol"},{"key":"4548_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","volume":"163","author":"MJ Silverberg","year":"2015","unstructured":"Silverberg\u00a0MJ, Lau\u00a0B, Achenbach\u00a0CJ et\u00a0al (2015) Cumulative incidence of cancer among persons with HIV in north america: a cohort study. Ann Intern Med 163:507\u2013518","journal-title":"Ann Intern Med"},{"key":"4548_CR57","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cir1012","volume":"54","author":"MJ Silverberg","year":"2012","unstructured":"Silverberg\u00a0MJ, Lau\u00a0B, Justice\u00a0AC et al (2012) Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 54:1026\u20131034","journal-title":"Clin Infect Dis"},{"key":"4548_CR58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2016.69.1642","volume":"35","author":"JA Sparano","year":"2017","unstructured":"Sparano\u00a0JA, Lee\u00a0JY, Palefsky\u00a0J et al (2017) Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: a phase II AIDS malignancy consortium trial. J\u00a0Clin Oncol 35:727\u2013733","journal-title":"J Clin Oncol"},{"key":"4548_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz408","author":"EA Stier","year":"2019","unstructured":"Stier\u00a0EA, Lensing\u00a0SY, Darragh\u00a0TM et al (2019) Prevalence of and risk factors for anal high-grade squamous intraepithelial lesions in women living with human Immunodeficiency virus. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciz408","journal-title":"Clin Infect Dis"},{"key":"4548_CR60","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IDR.S178381","volume":"12","author":"ZQ Toh","year":"2019","unstructured":"Toh\u00a0ZQ, Kosasih\u00a0J, Russell\u00a0FM et\u00a0al (2019) Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infect Drug Resist 12:1951\u20131967","journal-title":"Infect Drug Resist"},{"key":"4548_CR61","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","volume":"67","author":"EA Van Dyne","year":"2018","unstructured":"Van Dyne\u00a0EA, Henley\u00a0SJ, Saraiya\u00a0M et al (2018) Trends in human papillomavirus-associated cancers\u2014United States, 1999\u20132015. MMWR Morb Mortal Wkly Rep 67:918\u2013924","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4548_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/DCR.0b013e318207039a","volume":"54","author":"SE Weis","year":"2011","unstructured":"Weis\u00a0SE, Vecino\u00a0I, Pogoda\u00a0JM et al (2011) Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a\u00a0primary care population of HIV-infected men and women. Dis Colon Rectum 54:433\u2013441","journal-title":"Dis Colon Rectum"},{"key":"4548_CR63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ijmm.2015.08.019","volume":"305","author":"U Wieland","year":"2015","unstructured":"Wieland\u00a0U, Hellmich\u00a0M, Wetendorf\u00a0J et al (2015) Smoking and anal high-risk human papillomavirus DNA loads in HIV-positive men who have sex with men. Int J Med Microbiol 305:689\u2013696","journal-title":"Int J Med Microbiol"},{"key":"4548_CR64","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","volume":"67","author":"TJ Wilkin","year":"2018","unstructured":"Wilkin\u00a0TJ, Chen\u00a0H, Cespedes\u00a0MS et al (2018) A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: aIDS clinical trials group protocol A5298. Clin Infect Dis 67:1339\u20131346","journal-title":"Clin Infect Dis"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04548-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04548-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04548-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T19:51:50Z","timestamp":1614455510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04548-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4548"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04548-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"17 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Wieland und F.\u00a0Oellig geben an, dass kein Interessenkonflikt besteht. A.\u00a0Kreuter hat Referentenhonorare von MSD Sharp & Dohme GmbH erhalten und war im Advisory Board von MSD Sharp & Dohme GmbH t\u00e4tig.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}